BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38453743)

  • 21. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
    Jang SI; Lee HK; Chang EJ; Kim S; Kim SY; Hong IY; Kim JK; Lee HS; Yang J; Cho JH; Lee DK
    Cancer Immunol Immunother; 2023 Aug; 72(8):2757-2768. PubMed ID: 37165046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer.
    Chen W; Zhou Y; Xie F; Butler RK; Jeon CY; Luong TQ; Zhou B; Lin YC; Lustigova E; Pisegna JR; Kim S; Wu BU
    Am J Gastroenterol; 2023 Jan; 118(1):157-167. PubMed ID: 36227806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
    Thurin NH; Bosco-Levy P; Blin P; Rouyer M; Jové J; Lamarque S; Lignot S; Lassalle R; Abouelfath A; Bignon E; Diez P; Gross-Goupil M; Soulié M; Roumiguié M; Le Moulec S; Debouverie M; Brochet B; Guillemin F; Louapre C; Maillart E; Heinzlef O; Moore N; Droz-Perroteau C
    BMC Med Res Methodol; 2021 May; 21(1):95. PubMed ID: 33933001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Validation of the Veterans Affairs Eosinophilic Esophagitis Cohort.
    Low EE; Song Q; Yadlapati R; Dellon ES; Aceves S; Liu L; Gupta S; Choksi YA; Shah SC
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3030-3040.e4. PubMed ID: 37031716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of code based algorithms to identify primary open angle glaucoma (POAG) in Veterans Affairs (VA) administrative databases.
    Biggerstaff KS; Frankfort BJ; Orengo-Nania S; Garcia J; Chiao E; Kramer JR; White D
    Ophthalmic Epidemiol; 2018 Apr; 25(2):162-168. PubMed ID: 28945495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Mapel DW; Roberts MH; Sama S; Bobbili PJ; Cheng WY; Duh MS; Nguyen C; Thompson-Leduc P; Van Dyke MK; Rothnie KJ; Sundaresan D; Certa JM; Whiting TS; Brown JL; Roblin DW
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1687-1698. PubMed ID: 34135580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records.
    Ke C; Stukel TA; Luk A; Shah BR; Jha P; Lau E; Ma RCW; So WY; Kong AP; Chow E; Chan JCN
    BMC Med Res Methodol; 2020 Feb; 20(1):35. PubMed ID: 32093635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Portable Electronic Health Record Based Algorithms to Identify Individuals with Diabetic Retinopathy.
    Breeyear JH; Mitchell SL; Nealon CL; Hellwege JN; Charest B; Khakharia A; Halladay CW; Yang J; Garriga GA; Wilson OD; Basnet TB; Hung AM; Reaven PD; Meigs JB; Rhee MK; Sun Y; Lynch MG; Sobrin L; Brantley MA; Sun YV; Wilson PW; Iyengar SK; Peachey NS; Phillips LS; Edwards TL; Giri A
    medRxiv; 2024 Jan; ():. PubMed ID: 38014167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.
    Omino R; Mittal S; Kramer JR; Chayanupatkul M; Richardson P; Kanwal F
    Dig Dis Sci; 2017 May; 62(5):1180-1185. PubMed ID: 28271305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer.
    Peng HY; Chang MC; Hu CM; Yang HI; Lee WH; Chang YT
    Ann Surg Oncol; 2019 Mar; 26(3):807-814. PubMed ID: 30569296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
    Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
    Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.
    Keane MG; Horsfall L; Rait G; Pereira SP
    BMJ Open; 2014 Nov; 4(11):e005720. PubMed ID: 25410605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of Methods to Identify Individuals With Lower Extremity Amputation Using Department of Veterans Affairs Electronic Medical Records.
    Meadows M; Peterson A; Boyko EJ; Littman AJ
    Arch Rehabil Res Clin Transl; 2022 Mar; 4(1):100182. PubMed ID: 35282148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.
    Rückert F; Brussig T; Kuhn M; Kersting S; Bunk A; Hunger M; Saeger HD; Niedergethmann M; Post S; Grützmann R
    Pancreatology; 2013; 13(3):243-9. PubMed ID: 23719595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
    Okada Y; Nishiwada S; Yamamura K; Sho M; Baba H; Takayama T; Goel A
    Eur J Cancer; 2021 Mar; 146():125-134. PubMed ID: 33607476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of case-finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data.
    Weinstein EJ; Stephens-Shields A; Loabile B; Yuh T; Silibovsky R; Nelson CL; O'Donnell JA; Hsieh E; Hanberg JS; Akgün KM; Tate JP; Lo Re V
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1184-1191. PubMed ID: 34170057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and electronic health record validation of an algorithm for identifying patients with Duchenne muscular dystrophy in US administrative claims.
    Schrader R; Posner N; Dorling P; Senerchia C; Chen Y; Beaverson K; Seare J; Garnier N; Walker V; Alvir J; Mahn M; Merla V; Zhang Y; Landis C; Buikema AR
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1033-1044. PubMed ID: 37610111
    [No Abstract]   [Full Text] [Related]  

  • 40. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.